Verrica Pharmaceuticals (NASDAQ: VRCA)
$0.66
(-5.7%)
-$0.04
Price as of January 10, 2025, 4:00 p.m. ET
Verrica Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Verrica Pharmaceuticals Company Info
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
News & Analysis
Featured Article
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday
The company's shares dropped because it will require financing to help launch its first marketed product.
Jim Halley | Jul 24, 2023
Featured Article
Why Verrica Pharmaceuticals Stock Is Getting Pummeled Today
The Food and Drug Administration delivered some bad news regarding the company's dermatology candidate.
Cory Renauer | Sep 21, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.